Chris Whitehouse, a public affairs consultant and expert on medical technology policy and regulation at Whitehouse Communications, reflects on the results of the recent DHSC-commissioned National Voices survey examining patient experiences with devices prescribed under Part IX of the NHS Drug Tariff
2026 will mark a major turning point for NHS procurement, with value-based procurement (VBP) set to be rolled out across NHS England, transforming the way medical technologies are assessed and purchased. That is the message from health policy lobbyist Chris Whitehouse of Whitehouse Communications, w
Integrating AI into medical software has the potential to enhance diagnosis, personalise treatments and streamline workflows. However, AI outputs must be regulated to ensure they are accurate and safe. As medical AI rapidly advances, frameworks must evolve just as fast, creating challenges and oppor
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, flags new guidance from the NHS’s MedTech evaluator. NICE has published updates to its health technology evaluation guidance (manuals PMG36 and PMG48) following consultations
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, encourages MedTech trade bodies to engage in shaping new government guidance on declaration of payments. New guidelines will be published by Government to require MedTech sup
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights the importance of a call for evidence on AI regulation in MedTech. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a pivotal “Call
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers highlights a new UK/Singapore joint venture to encourage innovation in MedTech. The UK and Singapore have launched a groundbreaking “regulato
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers assesses the positive implications for MedTech of a controversial decision to allow government to dictate the level of value thresholds adopt
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers encourages industry engagement as the UK’s Department of Health and Social Care takes a further big step towards delivering value based procu
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers highlights funding for work to develop a new mobile quantum brain scanner. The UK Ministry of Defence has announced funding for the world’s f
Martin Murphy, Principal Consultant at 42 Technology explains what impact the FDA’s upcoming new regulation will have on drug delivery device developers. The regulatory world of medical devices is undergoing one of the most significant transformations in nearly three decades. The long-standing Quali
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, looks at the impact of a major grant from the Wellcome Trust to fund development of new standards for digital mental health apps. UK medical
